Paragon 28FNA
FNA
About: Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.
Employees: 574
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
889% more call options, than puts
Call options by funds: $188K | Put options by funds: $19K
67% more funds holding in top 10
Funds holding in top 10: 3 [Q2] → 5 (+2) [Q3]
3.26% more ownership
Funds ownership: 58.0% [Q2] → 61.26% (+3.26%) [Q3]
2% more funds holding
Funds holding: 110 [Q2] → 112 (+2) [Q3]
10% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 21
6% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 34
2% more capital invested
Capital invested by funds: $329M [Q2] → $335M (+$6.22M) [Q3]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$13
30%
upside
Avg. target
$14
40%
upside
High target
$15
50%
upside
2 analyst ratings
2 positive
100%
0 neutral
0%
0 negative
0%
Canaccord Genuity Kyle Rose 100% 1-year accuracy 4 / 4 met price target | 50%upside $15 | Buy Maintained | 13 Nov 2024 |
Needham Mike Matson 50% 1-year accuracy 58 / 117 met price target | 30%upside $13 | Buy Maintained | 13 Nov 2024 |
Financial journalist opinion
Based on 98 articles about FNA published over the past 30 days
Neutral
Business Wire
1 week ago
Paragon 28 Appoints Dave Demski to Board of Directors
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), (the “Company”) a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr. Demski brings a wealth of global orthopedic expertise, with over two decades of executive leadership experience. With the addition of Mr. Demski, the Company increased the size of its Board of Directors from eight members to nine members and has.
Negative
Benzinga
1 week ago
Top 3 Health Care Stocks That May Collapse This Quarter
As of Dec. 11, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Positive
Zacks Investment Research
2 weeks ago
Wall Street Analysts Predict a 39.67% Upside in Paragon 28, Inc. (FNA): Here's What You Should Know
The consensus price target hints at a 39.7% upside potential for Paragon 28, Inc. (FNA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Neutral
PRNewsWire
2 weeks ago
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Paragon 28, Inc.(FNA) Shareholders
NEW YORK , Dec. 2, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Paragon 28, Inc. ("Paragon 28, Inc." or the "Company") (NYSE: FNA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Paragon 28, Inc. investors who were adversely affected by alleged securities fraud between May 5, 2023 and September 20, 2024.
Neutral
Accesswire
3 weeks ago
Paragon 28, Inc. Class Action: Levi & Korsinsky Reminds Paragon 28, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 29, 2024 - FNA
NEW YORK, NY / ACCESSWIRE / November 29, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=114144&wire=1 or contact Joseph E. Levi, Esq.
Neutral
GlobeNewsWire
3 weeks ago
FNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Paragon 28, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Paragon 28, Inc. (“Paragon 28” or “the Company”) (NYSE: FNA) and certain of its officers.
Neutral
Accesswire
3 weeks ago
Investors who Lost Money on Paragon 28, Inc. (FNA) Should Contact Levi & Korsinsky About Pending Class Action - FNA
NEW YORK, NY / ACCESSWIRE / November 29, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=114103&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
3 weeks ago
Deadline TODAY: The Schall Law Firm Invites Investors To Reach Out About Taking Part In A Lawsuit Against Paragon 28, Inc.
LOS ANGELES, CA / ACCESSWIRE / November 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 5, 2023 and August 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before November 29, 2024.
Neutral
Business Wire
3 weeks ago
FNA Investors Have Opportunity to Lead Paragon 28, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--FNA Investors Have Opportunity to Lead Paragon 28, Inc. Securities Fraud Lawsuit with the Schall Law Firm.
Neutral
PRNewsWire
3 weeks ago
FNA Investors Have Opportunity to Lead Paragon 28, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES , Nov. 29, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE: FNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 5, 2023 and August 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before November 29, 2024.
Charts implemented using Lightweight Charts™